5 Oncology Practice Loan Mistakes That Cost Owners the Most
Oncology practice loan mistakes can carry a heavier price than in many specialties, because independent cancer practices often buy costly drugs before they are reimbursed and invest in infusion suites, imaging and radiation equipment. Whether you are acquiring a practice, opening a satellite clinic or buying out a partner, the structure of your financing can affect cash flow for years.
Here are five mistakes oncology owners make with financing and how to avoid them. Loan programs, terms and eligibility vary by lender and borrower, and nothing here is legal, tax, accounting or billing advice.
Mistake 1: Choosing the Wrong Type of Loan for the Purpose
An oncology practice may need capital for a practice purchase, a building, a linear accelerator, an infusion suite renovation or drug inventory. Each one produces income on a different schedule, and the financing should reflect that.
Common mismatches include:
- Financing a practice acquisition over a short term that collides with drug purchasing and payroll
- Using a line of credit meant for drug inventory to pay for an infusion suite build-out
- Paying cash for major treatment or imaging equipment and leaving too little in reserve for buy-and-bill cycles
- Combining the practice and a cancer center building into one loan without weighing whether separate financing would offer more flexibility
For a purchase or property project, SBA 7(a) loans for medical practices and real estate may be one option, depending on the buyer, the practice, the use of proceeds, program rules and lender review. Our page on oncology practice acquisition loans explains how these deals are often put together.
Mistake 2: Borrowing Too Little and Running Short on Working Capital
Oncology can have a wider gap between spending and collecting than many specialties. A practice may pay distributors for chemotherapy and immunotherapy drugs well before Medicare and commercial insurers reimburse the claim. A new owner who borrows only enough to close may find that gap harder to manage than expected.
Costs that are often underestimated include:
- Drug inventory and the timing between purchase and reimbursement
- Payer contracts, Medicare and Medicaid enrollments and drug purchasing arrangements, which should not be assumed to transfer after a change of ownership
- Retaining oncology nurses, pharmacists and support staff through a transition
- Prior authorization work and billing staff needed to keep claims moving
Including working capital and credit lines for oncology practices in the original plan can give an owner more room to handle these swings. For a closer look at the drug purchasing cycle, read our guide on managing cash flow under buy-and-bill.
Mistake 3: Comparing Offers Only on Rate or Monthly Payment
Rate and payment are easy to compare, but they leave out much of what makes a loan work or fail for an oncology practice. Large equipment and acquisition loans often come with terms that matter as much as the price.
When comparing offers, look at:
- Term: whether the repayment period fits the useful life of the asset or the expected return from the acquisition
- Fees: origination, packaging, legal, appraisal and closing costs
- Prepayment provisions: what happens if you refinance, add partners or sell
- Collateral and guarantees: which assets are pledged and which physicians sign personally
- Covenants: financial ratios and reporting the practice must maintain
- Rate structure: fixed or variable, and how a change would affect payments
Large equipment loans deserve extra attention, because treatment and imaging technology can change over the life of the loan and the practice may want to upgrade before the balance is paid off. A loan with a slightly higher rate but more room to grow may serve a practice better. Review the complete terms with your accountant and healthcare attorney before signing.
Mistake 4: Stacking Short-Term Debt
When drug bills come due before reimbursement arrives, some practices reach for a series of short-term solutions: a credit card, an online advance, a high-cost lease, then more of the same. Each may seem manageable alone, but together the frequent payments can consume a large share of collections.
Layered short-term debt can also make it harder to qualify for longer-term financing, because lenders review existing obligations closely. If your practice is carrying several of these payments, consider exploring oncology debt consolidation and refinancing. Not every obligation can be refinanced, and options depend on the terms of the existing debt, the practice’s cash flow and lender review.
Mistake 5: Applying Before You Are Prepared
Lenders financing oncology practices want to understand both the physicians and the economics of the practice, including how drug revenue and margins fit together. A rushed application can cause delays, less favorable terms or a decline that might have been avoided.
Before applying, it can help to collect:
- Business and personal tax returns for recent years
- Current financial statements, along with collection and receivables reports
- A schedule of existing debts, equipment leases and payments
- A clear description of how the funds will be used
- For an acquisition, the seller’s financials, the letter of intent and details on payer mix and referral sources
Be ready to explain how drug revenue affects your margins and any changes in reimbursement. Our article on what lenders look for in an oncology loan request covers these points in more depth.
How to Avoid Oncology Practice Loan Mistakes
Most oncology practice loan mistakes come from overlooking the timing of drug costs or looking at one number instead of the full offer. A few habits can help:
- Match each loan to the asset or project it pays for
- Plan for drug inventory and reimbursement timing, not just the purchase price
- Compare full terms, not only the rate
- Avoid stacking short-term obligations to fill long-term gaps
- Prepare clear financials and a use-of-funds plan before you apply
Final Thoughts
Thoughtful financing can help an oncology practice stay independent, add services and invest in the equipment patients need. A poorly structured loan can limit those choices. Taking time to plan and prepare can lead to a better outcome.
US Medical Funding helps oncologists finance acquisitions, expansions, equipment, working capital and refinancing. Learn more about our oncology practice financing options.
